If blood sugar levels are not lowered effectively, this may also lead to serious complications such as diabetic ketoacidosis
GLP-1 is a hormone in your small intestine with several important functions
The effect of GLP-1R-based agonists on MASLD and its risk factors First of all, genetic proxied effects of all kinds of GLP-1R-based agonists were all causally associated with reduced risk of MASLD in the discovery dataset (GIPR/GLP-1R agonist: odds ratio (OR): 0.17, 95% Confidence Interval (95%CI): 0.050.52, P = 2.07 10 3
In particular dietary resistant starch has been shown in studies to upregulate GLP-1 and PYY (Peptide YY, a hormone that can decrease appetite) in a sustained manner
Apart from these cardiovascular mechanisms, increased BMI independently correlates with mortality risk
GLP-1 also reduces levels of glucagon, a hormone that typically raises blood sugar, further stabilizing your bodys blood glucose response